AVITA Medical (RCEL) Net Margin Growth (1y) (2019 - 2025)
AVITA Medical (RCEL) Net Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 201.00 |
| 10 | AVITA Medical | 133.73 Mn | 117.39 Mn | 14.31 Mn | 6,261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,261.00 |
| Sep 30, 2025 | 486.00 |
| Jun 30, 2025 | 4,688.00 |
| Mar 31, 2025 | 9,240.00 |
| Dec 31, 2024 | -1,437.00 |
| Sep 30, 2024 | -1,906.00 |
| Jun 30, 2024 | -1,295.00 |
| Mar 31, 2024 | -8,064.00 |
| Dec 31, 2023 | -27,622.00 |
| Sep 30, 2023 | -239.00 |
| Mar 31, 2023 | 3,813.00 |
| Sep 30, 2022 | 241.00 |
| Mar 31, 2022 | -5,710.00 |
| Sep 30, 2021 | 13,824.00 |
| Jun 30, 2021 | 27,690.00 |
| Mar 31, 2021 | 31,972.00 |
| Dec 31, 2020 | 21,170.00 |
| Sep 30, 2020 | -9,239.00 |
| Mar 31, 2020 | -2,661.00 |
| Dec 31, 2019 | 28,025.00 |